Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone Bromide

NCT01366365 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adults

Interventions

DRUG: methylnaltrexone
DRUG: placebo

Sponsor

Bausch Health Americas, Inc.